CRISPR Therapeutics AGNASDAQ:CRSP
- LAST PRICE55.6700
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots55.3600/ 1
- Ask / Lots57.0000/ 1
- Open / Previous Close0.0000 / 55.6700
- Day Range---
- 52 Week Range
- Volume830
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CRSP |
|---|---|---|
| 09:32 ET | 26586 | 57.65 |
| 09:34 ET | 19166 | 57.94 |
| 09:36 ET | 5075 | 57.38 |
| 09:38 ET | 8612 | 57.29 |
| 09:39 ET | 4792 | 57.13 |
| 09:41 ET | 7873 | 57.11 |
| 09:43 ET | 4070 | 56.94 |
| 09:45 ET | 1704 | 56.73 |
| 09:48 ET | 8579 | 56.79 |
| 09:50 ET | 2046 | 56.679 |
| 09:52 ET | 1450 | 56.41 |
| 09:54 ET | 2150 | 56.5 |
| 09:56 ET | 5038 | 56.57 |
| 09:57 ET | 400 | 56.57 |
| 09:59 ET | 5749 | 56.565 |
| 10:01 ET | 5297 | 56.49 |
| 10:03 ET | 2718 | 56.575 |
| 10:06 ET | 3840 | 56.5 |
| 10:08 ET | 3758 | 56.37 |
| 10:10 ET | 4030 | 56.17 |
| 10:12 ET | 8128 | 56.13 |
| 10:14 ET | 4564 | 56.12 |
| 10:15 ET | 2415 | 56.1425 |
| 10:17 ET | 4282 | 55.946 |
| 10:19 ET | 5771 | 55.83 |
| 10:21 ET | 3504 | 55.6875 |
| 10:24 ET | 8605 | 55.63 |
| 10:26 ET | 2850 | 55.8 |
| 10:28 ET | 3177 | 55.82 |
| 10:30 ET | 3000 | 55.8 |
| 10:32 ET | 2182 | 55.7 |
| 10:33 ET | 652 | 55.74 |
| 10:35 ET | 1220 | 55.74 |
| 10:37 ET | 2619 | 55.74 |
| 10:39 ET | 1300 | 55.67 |
| 10:42 ET | 6184 | 55.48 |
| 10:44 ET | 2078 | 55.41 |
| 10:46 ET | 2876 | 55.4 |
| 10:48 ET | 3677 | 55.39 |
| 10:50 ET | 3273 | 55.42 |
| 10:51 ET | 6292 | 55.6592 |
| 10:53 ET | 2443 | 55.58 |
| 10:55 ET | 4108 | 55.51 |
| 10:57 ET | 4200 | 55.385 |
| 11:00 ET | 2574 | 55.495 |
| 11:02 ET | 2323 | 55.46 |
| 11:04 ET | 3448 | 55.51 |
| 11:06 ET | 9724 | 55.6366 |
| 11:08 ET | 2654 | 55.5 |
| 11:09 ET | 816 | 55.57 |
| 11:11 ET | 600 | 55.63 |
| 11:13 ET | 1534 | 55.54 |
| 11:15 ET | 400 | 55.48 |
| 11:18 ET | 13870 | 55.44 |
| 11:20 ET | 4822 | 55.5942 |
| 11:22 ET | 2046 | 55.4607 |
| 11:24 ET | 601 | 55.5013 |
| 11:26 ET | 1100 | 55.535 |
| 11:27 ET | 700 | 55.61 |
| 11:29 ET | 1600 | 55.645 |
| 11:31 ET | 1700 | 55.7 |
| 11:33 ET | 3180 | 55.6515 |
| 11:36 ET | 1426 | 55.675 |
| 11:38 ET | 2800 | 55.72 |
| 11:40 ET | 2455 | 55.7 |
| 11:42 ET | 2531 | 55.71 |
| 11:44 ET | 1987 | 55.5901 |
| 11:45 ET | 3326 | 55.5 |
| 11:47 ET | 3630 | 55.7 |
| 11:49 ET | 2892 | 55.71 |
| 11:51 ET | 8138 | 55.8 |
| 11:54 ET | 1165 | 55.78 |
| 11:56 ET | 1885 | 55.72 |
| 11:58 ET | 6391 | 56.02 |
| 12:00 ET | 1200 | 56.05 |
| 12:02 ET | 1700 | 55.96 |
| 12:03 ET | 10056 | 55.92 |
| 12:05 ET | 10860 | 55.68 |
| 12:07 ET | 1215 | 55.7 |
| 12:09 ET | 950 | 55.6201 |
| 12:12 ET | 1864 | 55.66 |
| 12:14 ET | 608 | 55.68 |
| 12:16 ET | 8833 | 55.8072 |
| 12:18 ET | 5332 | 55.77 |
| 12:20 ET | 2047 | 55.85 |
| 12:21 ET | 1800 | 55.74 |
| 12:23 ET | 600 | 55.7195 |
| 12:27 ET | 600 | 55.74 |
| 12:30 ET | 1400 | 55.75 |
| 12:32 ET | 2401 | 55.6795 |
| 12:34 ET | 331 | 55.63 |
| 12:36 ET | 608 | 55.6 |
| 12:38 ET | 773 | 55.69 |
| 12:39 ET | 1634 | 55.765 |
| 12:41 ET | 351 | 55.7065 |
| 12:43 ET | 827 | 55.67 |
| 12:45 ET | 349 | 55.72 |
| 12:48 ET | 1473 | 55.82 |
| 12:50 ET | 3397 | 55.74 |
| 12:52 ET | 650 | 55.7 |
| 12:54 ET | 900 | 55.6 |
| 12:56 ET | 647 | 55.625 |
| 12:57 ET | 900 | 55.59 |
| 12:59 ET | 1616 | 55.6307 |
| 01:01 ET | 1633 | 55.64 |
| 01:03 ET | 100 | 55.615 |
| 01:06 ET | 950 | 55.605 |
| 01:08 ET | 1110 | 55.61 |
| 01:10 ET | 2588 | 55.6 |
| 01:12 ET | 2408 | 55.63 |
| 01:14 ET | 400 | 55.6991 |
| 01:15 ET | 1300 | 55.6933 |
| 01:17 ET | 1638 | 55.64 |
| 01:19 ET | 1371 | 55.65 |
| 01:21 ET | 3893 | 55.62 |
| 01:24 ET | 823 | 55.62 |
| 01:26 ET | 991 | 55.5 |
| 01:28 ET | 708 | 55.565 |
| 01:30 ET | 400 | 55.55 |
| 01:32 ET | 400 | 55.57 |
| 01:33 ET | 229 | 55.555 |
| 01:35 ET | 100 | 55.56 |
| 01:37 ET | 1049 | 55.535 |
| 01:39 ET | 900 | 55.505 |
| 01:42 ET | 3836 | 55.52 |
| 01:44 ET | 2910 | 55.511 |
| 01:46 ET | 800 | 55.555 |
| 01:48 ET | 400 | 55.49 |
| 01:50 ET | 3654 | 55.51 |
| 01:51 ET | 1819 | 55.56 |
| 01:53 ET | 640 | 55.5599 |
| 01:55 ET | 1116 | 55.545 |
| 01:57 ET | 1451 | 55.615 |
| 02:00 ET | 2052 | 55.69 |
| 02:02 ET | 452 | 55.68 |
| 02:04 ET | 1483 | 55.67 |
| 02:08 ET | 900 | 55.66 |
| 02:09 ET | 615 | 55.65 |
| 02:11 ET | 1700 | 55.6209 |
| 02:13 ET | 1200 | 55.59 |
| 02:15 ET | 1719 | 55.555 |
| 02:18 ET | 937 | 55.58 |
| 02:20 ET | 2843 | 55.58 |
| 02:22 ET | 150 | 55.5789 |
| 02:24 ET | 11908 | 55.62 |
| 02:26 ET | 1575 | 55.72 |
| 02:27 ET | 2021 | 55.6939 |
| 02:29 ET | 600 | 55.6712 |
| 02:31 ET | 550 | 55.645 |
| 02:33 ET | 647 | 55.67 |
| 02:36 ET | 11415 | 55.62 |
| 02:38 ET | 700 | 55.615 |
| 02:40 ET | 420 | 55.575 |
| 02:42 ET | 700 | 55.56 |
| 02:44 ET | 963 | 55.53 |
| 02:45 ET | 300 | 55.565 |
| 02:47 ET | 1662 | 55.5899 |
| 02:49 ET | 2257 | 55.6 |
| 02:51 ET | 1150 | 55.65 |
| 02:54 ET | 2449 | 55.73 |
| 02:56 ET | 1100 | 55.7407 |
| 02:58 ET | 755 | 55.675 |
| 03:00 ET | 1257 | 55.695 |
| 03:02 ET | 723 | 55.68 |
| 03:03 ET | 1056 | 55.605 |
| 03:05 ET | 607 | 55.588 |
| 03:07 ET | 4260 | 55.61 |
| 03:09 ET | 2409 | 55.565 |
| 03:12 ET | 400 | 55.5834 |
| 03:14 ET | 4598 | 55.61 |
| 03:16 ET | 2754 | 55.645 |
| 03:18 ET | 575 | 55.6344 |
| 03:20 ET | 4159 | 55.605 |
| 03:21 ET | 1600 | 55.62 |
| 03:23 ET | 2690 | 55.66 |
| 03:25 ET | 500 | 55.66 |
| 03:27 ET | 1240 | 55.6701 |
| 03:30 ET | 1000 | 55.72 |
| 03:32 ET | 4862 | 55.68 |
| 03:34 ET | 1663 | 55.65 |
| 03:36 ET | 3273 | 55.6252 |
| 03:38 ET | 2130 | 55.59 |
| 03:39 ET | 1928 | 55.56 |
| 03:41 ET | 6347 | 55.581 |
| 03:43 ET | 1513 | 55.57 |
| 03:45 ET | 1725 | 55.575 |
| 03:48 ET | 6129 | 55.52 |
| 03:50 ET | 2550 | 55.54 |
| 03:52 ET | 6599 | 55.59 |
| 03:54 ET | 11731 | 55.715 |
| 03:56 ET | 20929 | 55.69 |
| 03:57 ET | 11837 | 55.67 |
| 03:59 ET | 30641 | 55.67 |
May 10, 2024
DJ Crispr Therapeutics Is Maintained at Outperform by Oppenheimer, from 12:58PM ET on Friday May 10, 2024 by Dow Jones
12:58PM ET on Friday May 10, 2024 by Dow Jones
May 9, 2024
DJ Crispr Therapeutics Price Target Maintained With a $86.00/Share by JMP Securities, from 2:34PM ET on Thursday May 09, 2024 by Dow Jones
2:34PM ET on Thursday May 09, 2024 by Dow JonesDJ Crispr Therapeutics Is Maintained at Equal-Weight by Wells Fargo, from 12:14PM ET on Thursday May 09, 2024 by Dow Jones
12:14PM ET on Thursday May 09, 2024 by Dow JonesDJ Crispr Therapeutics Is Maintained at Equal-Weight by Barclays, from 11:00AM ET on Thursday May 09, 2024 by Dow Jones
11:00AM ET on Thursday May 09, 2024 by Dow JonesDJ Crispr Therapeutics Is Maintained at Buy by Needham, from 9:50AM ET on Thursday May 09, 2024 by Dow Jones
9:50AM ET on Thursday May 09, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
CRISPR Therapeutics AG | 4.7B | -20.6x | --- |
Apellis Pharmaceuticals Inc | 5.1B | -12.1x | --- |
Insmed Inc | 3.7B | -4.8x | --- |
Ultragenyx Pharmaceutical Inc | 3.5B | -5.3x | --- |
Axsome Therapeutics Inc | 3.7B | -12.1x | --- |
Genmab A/S | 19.5B | 24.6x | +22.71% |
Company Information
CRISPR Therapeutics AG is a Switzerland-based gene editing company focused on the development of CRISPR/Cas9-based therapeutics. CRISPR/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) and is a technology for gene editing, the process of precisely altering specific sequences of genomic DNA. The Company aims to apply this technology to disrupt, delete, correct and insert genes to treat genetically-defined diseases and to engineer advanced cellular therapies. The Company has acquired the rights to the intellectual property (IP) encompassing CRISPR/Cas9 and related technologies and is also involved in its own IP research and additional in-licensing efforts. The Company product development and partnership strategies are designed to exploit the full potential of the CRISPR/Cas9 platform while maximizing the probability of successfully developing their product candidates.
Contact Information
- Headquarters
- Baarerstrasse 14ZUG, ZUG, Switzerland 6300
- Phone
- ---
- Fax
- ---
Executives
- Chairman of the Board, Chief Executive Officer
- Samarth Kulkarni
- Chief Financial Officer
- Raju Prasad
- General Counsel, Secretary
- James Kasinger
- Lead Independent Director
- Douglas Treco
- Independent Director
- Ali Behbahani
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $4.7B |
|---|---|
Revenue (TTM) | $271.7M |
Shares Outstanding | 84.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.78 |
EPS | $-2.70 |
Book Value | $23.52 |
P/E Ratio | -20.6x |
Price/Sales (TTM) | 17.4 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -109.91% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
